A detailed history of Adar1 Capital Management, LLC transactions in Gh Research PLC stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 1,850 shares of GHRS stock, worth $15,410. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,850
Previous 12,583 85.3%
Holding current value
$15,410
Previous $134 Million 83.92%
% of portfolio
0.0%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.5 - $14.81 $112,696 - $158,955
-10,733 Reduced 85.3%
1,850 $21.6 Million
Q1 2024

May 15, 2024

BUY
$5.34 - $11.09 $67,193 - $139,545
12,583 New
12,583 $134 Million

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $433M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.